San Francisco, USA
Weave Bio is an AI-native regulatory automation management platform redefining regulatory submissions for novel therapeutic candidates. Designed for pharma, biotechs, CROs, and consultants, the Weave Platform streamlines regulatory document preparation and lifecycle management by automating initial draft documents, extracting key insights, and integrating study data into a seamless, AI-enabled workflow. The platform accelerates regulatory processes, enabling faster drafting, high-quality reviews, and compliance with global standards. AutoIND, widely adopted for preclinical IND submissions, earned the “Biotech AI Innovation of the Year” award. And with AutoCT, Weave expanded capabilities into clinical-stage submissions, building the foundation for a singular AI workbench for the entire therapy lifecycle. Backed by top investors in AI and life sciences, Weave is creating a new AI-enabled, human-driven platform to enhance efficiency, submission quality, and cost-effectiveness.
No key contacts have been added to this profile yet.
No reviews have been added to this profile yet.
This is the company profile page for Weave Bio on the Pharmaceutical Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.
